{
    "Symbol": "EW",
    "AssetType": "Common Stock",
    "Name": "Edwards Lifesciences Corp",
    "Description": "Edwards Lifesciences is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring.",
    "CIK": "1099800",
    "Exchange": "NYSE",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "LIFE SCIENCES",
    "Industry": "ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES",
    "Address": "ONE EDWARDS WAY, IRVINE, CA, US",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2022-12-31",
    "MarketCapitalization": "48932700000",
    "EBITDA": "1931500000",
    "PERatio": "32.57",
    "PEGRatio": "3.065",
    "BookValue": "9.55",
    "DividendPerShare": "0",
    "DividendYield": "0",
    "EPS": "2.47",
    "RevenuePerShareTTM": "8.7",
    "ProfitMargin": "0.283",
    "OperatingMarginTTM": "0.333",
    "ReturnOnAssetsTTM": "0.133",
    "ReturnOnEquityTTM": "0.261",
    "RevenueTTM": "5382400000",
    "GrossProfitTTM": "4303600000",
    "DilutedEPSTTM": "2.47",
    "QuarterlyEarningsGrowthYOY": "0.227",
    "QuarterlyRevenueGrowthYOY": "0.014",
    "AnalystTargetPrice": "88.52",
    "TrailingPE": "32.57",
    "ForwardPE": "30.12",
    "PriceToSalesRatioTTM": "8.48",
    "PriceToBookRatio": "7.54",
    "EVToRevenue": "8.54",
    "EVToEBITDA": "23.19",
    "Beta": "0.995",
    "52WeekHigh": "131.1",
    "52WeekLow": "67.13",
    "50DayMovingAverage": "76.96",
    "200DayMovingAverage": "86.42",
    "SharesOutstanding": "608313000",
    "DividendDate": "None",
    "ExDividendDate": "None"
}